J9173
HCPCSInj., durvalumab, 10 mg
Official HCPCS Level II long descriptor
Injection, durvalumab, 10 mg
HCPCS Level II code J9173 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj., durvalumab, 10 mg
Added to HCPCS: 2019-01-01
Nearby codes in J9
- J9144Daratumumab, hyaluronidase
- J9145Injection, daratumumab 10 mg
- J9150Daunorubicin injection
- J9153Inj daunorubicin, cytarabine
- J9155Degarelix injection
- J9161Inj denileuk difti-cxdl 1mcg
- J9171Docetaxel injection
- J9172Docetaxel (docivyx), 1 mg
- J9174Inj, docetaxel (beizray) 1mg
- J9175Elliotts b solution per ml
- J9176Injection, elotuzumab, 1mg
- J9177Inj enfort vedo-ejfv 0.25mg
- J9178Inj, epirubicin hcl, 2 mg
- J9179Eribulin mesylate injection
- J9181Etoposide injection
- J9183Gemcitabine intravesical sys
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.